InvestorsHub Logo
Followers 377
Posts 18023
Boards Moderated 3
Alias Born 04/29/2015

Re: venturecapp post# 78

Tuesday, 05/31/2016 7:54:47 AM

Tuesday, May 31, 2016 7:54:47 AM

Post# of 363
"So that’s all well and good, but why the upside at of the magnitude seen in the trial? Well, the positive data has implicationsbeyond an advancing of MIN-101 into a pivotal trial. Specifically, it paves the way for a potential partensrhip between Minerva and big pharma – a partnership that would not only secure the funding for the drug going forward (i.e. between now and commercialization) but also provide some near term development capital for Minerva, and – longer term – potential royalties on the back of a big pharma backed sales drive for the products in question."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NERV News